The read at a glance
Computed from the FY2023 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -9.26 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -6.53 — no flag raisedOK
- Earnings quality 65/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2023, as Cue Health Inc. reports it. History and quarterly detail are in the app.
- Product$64.2M
- Grant And Other Revenue$6.7M
- Service$2.5M
Leadership changes
From Cue Health Inc.'s own filings, the day they're filed.
- Rishi Reddy · departureeff. 2024-05-15
- Ayub Khattak · Directors · departureeff. 2024-05-14
- Aasim Javed · Chief Financial Officer · departureeff. 2024-05-13
Latest filings
- 8-K · Company announcement2024-05-28
- 8-K · Company announcement2024-05-16
- 8-K · Company announcement2024-05-01
- 8-K · Company announcement2024-04-24
- DEF 14A · Annual proxy (pay & governance)2024-04-22
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Cue Health Inc., every answer cited🔒
- The Intelligence Brief — added when Cue Health Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.